A study found daily aspirin treatment for five years was associated with a 34 percent reduction in 20-year colorectal cancer mortality, according to findings published in the Cancer Prevention Research journal.
Researchers analyzed data from 14,000 patients from four randomized, cardiovascular disease prevention trials who were on a daily aspirin regimen. An additional analysis of almost 3,000 patients with a history of colorectal cancer or adenoma found aspirin use reduced the occurrence of advanced adenomas by 28 percent and all adenomas by 17 percent.
Related Articles on Colorectal Cancer:
Report: Colorectal Cancer, Lung Cancer and Antibodies
Study: Virtual Colonoscopy Increases Colon Cancer Screening Rates
Study: American Ginseng Prevents Colon Cancer
Researchers analyzed data from 14,000 patients from four randomized, cardiovascular disease prevention trials who were on a daily aspirin regimen. An additional analysis of almost 3,000 patients with a history of colorectal cancer or adenoma found aspirin use reduced the occurrence of advanced adenomas by 28 percent and all adenomas by 17 percent.
Related Articles on Colorectal Cancer:
Report: Colorectal Cancer, Lung Cancer and Antibodies
Study: Virtual Colonoscopy Increases Colon Cancer Screening Rates
Study: American Ginseng Prevents Colon Cancer